- Report
- December 2022
- 190 Pages
Global
From €3960EUR$4,450USD£3,486GBP
- Report
- June 2024
- 183 Pages
Global
From €4004EUR$4,500USD£3,525GBP
- Report
- March 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,251GBP
- Report
- November 2023
- 366 Pages
Global
€4445EUR$4,995USD£3,913GBP
- Report
- November 2023
- 194 Pages
Global
€4445EUR$4,995USD£3,913GBP
- Report
- October 2023
- 108 Pages
Global
From €3500EUR$4,213USD£3,189GBP
- Report
- January 2025
- 132 Pages
Global
From €845EUR$950USD£744GBP
- Report
- January 2025
- 132 Pages
Global
From €845EUR$950USD£744GBP
The Aquaculture Vaccine market is a segment of the Animal Healthcare/Veterinary industry that focuses on the development and production of vaccines for aquatic species. Vaccines are used to protect fish, crustaceans, and mollusks from diseases caused by bacteria, viruses, fungi, and parasites. Vaccines are administered through injection, immersion, or oral delivery.
The Aquaculture Vaccine market is driven by the increasing demand for seafood, the growing awareness of animal welfare, and the need to protect aquatic species from disease. The market is also driven by advances in vaccine technology, such as the development of recombinant vaccines and the use of adjuvants.
Some companies in the Aquaculture Vaccine market include AquaVax, AquaHealth, AquaVet, AquaPharm, and AquaVet Pharma. Show Less Read more